Ep 76 | HRSA DRL Updates & 340B Rebate Comments
Update: 2025-09-15
Description
In this episode, Greg and Rob review recent changes made to the HRSA Audit Data Request List (DRL). They also discuss some of the comments provided by the public to HRSA regarding potential 340B rebate models, debate a recent change to a manufacturer’s contract pharmacy restrictions, and highlight some communication that has gone out to hospitals regarding a proposed CMS 340B drug acquisition cost survey expected in CY26.
SpendMend’s comments on HRSA’s proposed 340B rebate model: https://www.regulations.gov/comment/HRSA-2025-0001-1115
CMS proposed Medicare Part B 340B drug acquisition cost survey template: CMS-10931 | CMS
Got questions? Email us at 340BUnscripted@spendmend.com
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
